Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1147-1156

  Ter Steege, Jessica ^b   Vianen, Marieke ^b   Van Bilsen, Jolanda ^b   Bijlsma, Johannes ^b   Lafeber, Floris ^a   Wauben, Marca ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Autoantigen; Matrix Metalloproteinase; MMP 1; Rheumatoid Arthritis

Indexed keywords

EPITOPE; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PEPTIDE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ADULT; AGED; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CELL DIVISION; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; INTERLEUKIN-4; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0038657723     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
3. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
4. van Eden W, van der Zee R, Taams LS, Prakken AB, van Roon J, Wauben MH. Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunol Rev 1998;164:169-74.
5. Glant T, Csongor J, Szucs T. Immunopathologic role of proteoglycan antigens in rheumatoid joint disease. Scand J Immunol 1980;11:247-52.
6. Guerassimov A, Zhang Y, Banerjee S, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-25.
7. Londei M, Savill CM, Verhoef A, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci 1989;86:636-40.
8. Verheijden GF, Rijnders AW, Bos E, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
9. Blass S, Schumann F, Hain NA, Engel JM, Stuhlmuller B, Burmester GR. p205 is a major target of autoreactive T cells in rheumatoid arthritis. Arthritis Rheum 1999;42:971-80.
10. Prakken AB, van Eden W, Rijkers GT, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:1826-32.
11. Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996;17:466-70.
12. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998;12:1255-65.
13. Leech S. Molecular mimicry in autoimmune disease. Arch Dis Child 1998;79:448-51.
14. Abu-Shakra M, Buskila D, Shoenfeld Y. Molecular mimicry between host and pathogen: examples from parasites and implication. Immunol Lett 1999;67:147-52.
15. Laskin RS. Total condylar knee replacement in patients who have rheumatoid arthritis. A ten-year follow-up study. J Bone Joint Surg Am 1990;72:529-35.
16. Alsalameh S, Mollenhauer J, Hain N, Stock KP, Kalden JR, Burmester GR. Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases. Arthritis Rheum 1990;33:1477-86.
17. Fang Q, Sun YY, Cai W, Dodge GR, Lotke PA, Williams WV. Cartilage-reactive T cells in rheumatoid synovium. Int Immunol 2000;12:659-69.
18. van Roon JA, Lafeber FPJG, Bijlsma JWJ. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum 2001;44:3-12.
19. Wilbrink B, Nietfeld JJ, den Otter W, van Roy JL, Bijlsma JW, Huber-Bruning O. Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 1991;30:265-71.
20. Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 1999;90:65-78.
21. Van Bilsen JHM, Wagenaar-Hilbers JPA, Boot EPJ, van Eden W, Wauben MHM. Searching for cartilage-associated mimicry epitope in adjuvant arthritis. Autoimmunity 2002;35:201-10.
22. van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 1985;82:5117-20.
23. Wauben MH, van der Kraan M, Grosfeld-Stulemeyer MC, Joosten I. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule. Int Immunol 1997;9:281-90.
24. Van der Zee R, Anderton SM, Buskens CAF, Alonso de Velasco E, Van Eden W. Heat shock protein T-cell epitopes as immunogenic carriers in subunit vaccines. In: Maya HLS, editor. Peptides 1994. Proceedings of the 23rd European Peptides Symposium, Leiden, The Netherlands, 1994. Leiden: ESCOM; 1994:841-2.
25. Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
26. Verhoef CM, Van Roon JA, Vianen ME, Glaudemans CA, Lafeber FP, Bijlsma JW. Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis. Scand J Immunol 1999;50:427-32.
27. van Roon JAG, van Eden W, van Roy JLAM, Lafeber FJPG, Bijlsma JWJ. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997;100:459-63.
28. Verhoef CM, Van Roon JAG, Vianen ME, Bijlsma JWJ, Lafeber FPJG. Interleukin 10 (IL-10), not IL-4 or interferon-g production, correlates with progression of joint destruction in rheumatoid arthritis. J Rheumatol 2001;28:1960-6.
29. Maurice MM, Lankester AC, Bezemer AC, et al. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 1997;159:2973-8.
30. Matsuda M, Ulfgren AK, Lenkei R, et al. Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 1998;47:254-62.
31. Malmstrom V, Kjellen P, Holmdahl R. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response. J Autoimmun 1998;11:213-21.
32. Corthay A, Backlund J, Broddefalk J, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998;28:2580-90.
33. Kim HY, Kim WU, Cho ML, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.
34. Konttinen YT, Ainola M, Valleala H, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
35. Cunnane G, FitzGerald O, Hummel KM, Gay RE, Gay S, Bresnihan B. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 1999;38:34-42.
36. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
37. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
38. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T. Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1994;13:228-33.
39. Cawston TE, Mercer E, de Silva M, Hazleman BL. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum 1984;27:285-90.
40. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-75.
41. Manicourt DH, Fujimoto N, Obata K, Thonar EJ. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases I in patients with rheumatoid arthritis, Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 1995;38:1031-9.
42. Keyszer G, Lambiri I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999;26:251-8.
43. Cunnana G, Fitzgerald O, Beeton C, Cawston TE, Bresnihan B. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of matrix metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum 2001;44:2263-74.
44. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
45. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998;2:466-71.
46. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 1994;37:1115-26.
47. De Jong H, de Jager W, Taams LS, et al. Novel pan DR binding HSP60 peptides induce CD4 positive T cells producing TNFa, IL-1β and IL-10 in rheumatoid arthritis [abstract]. Arthritis Rheum 2002;45 Suppl:S487.
48. Nemoto O, Yamada H, Kikuchi T, et al. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. J Rheumatol 1997;24:1774-9.
49. Borghaei RC, Rawlings PL Jr, Mochan E. Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum 1998;41:1398-406.
50. Lubberts E, Joosten LA, van den Bersselaar L, et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999;163:4546-56.
51. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990;265:17238-45.
52. McCachren SS, Greer PK, Niedel JE. Regulation of human synovial fibroblast coliagenase messenger RNA by interleukin-1. Arthritis Rheum 1989;32:1539-45.
53. Mizel SB, Dayer JM, Krane SM, Mergenhagen SE. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci USA 1981;78:2474-7.
54. Van Bilsen JHM, Wagenaar-Hilbers JPA, van der Cammen MJF, van Dijk MEA, van Eden W, Wauben MHM. Successful immunotherapy with MMP-derived peptides in adjuvant arthritis depends on timing of peptide administration. Arthritis Res 2002;4:R2.